1.Blue Toe Syndrome as an Early Sign of Disseminated Intravascular Coagulation.
Kwang Hyun CHOI ; Jisook YOO ; Joon Won HUH ; Young In JEONG ; Min Soo KIM ; Mihn Sook JUE ; Hyang Joon PARK
Annals of Dermatology 2016;28(3):400-401
No abstract available.
Blue Toe Syndrome*
;
Disseminated Intravascular Coagulation*
3.Cholesterol crystal embolism of toe: report of a case.
Chinese Journal of Pathology 2007;36(12):857-858
Aged
;
Atherosclerosis
;
complications
;
Blue Toe Syndrome
;
diagnosis
;
etiology
;
metabolism
;
pathology
;
Cell Nucleus
;
Cholesterol
;
blood
;
Color
;
Epidermis
;
Female
;
Humans
;
Male
4.Blue Toe Syndrome due to Mobile Atheromatous Aorto-iliac Plaque Treated Successfully by Endovascular Aortic Repair.
Suy SOVANNARA ; Hyung Oh CHOI ; Nae Hee LEE
Soonchunhyang Medical Science 2017;23(2):124-127
Blue toe syndrome is characterized by tissue ischemia secondary to cholesterol crystal or atherothrombotic embolization. It leads to the occlusion of small vessels. The treatment option is usually surgery for most causes of blue toe syndrome. However, endovascular aortic repair by aorto-iliac stent graft become more and more popular because of its effectiveness and its less invasive characteristic. We present a 57-year-old man who suffered from blue toes syndrome on both legs caused by embolizing aorto-iliac lesions. Successful Endurant stent graft (Medtronic Vascular, Santa Rosa, CA, USA) was performed on infrarenal abdominal aorta and on proximal portion of right and left common iliac artery.
Aorta, Abdominal
;
Blood Vessel Prosthesis
;
Blue Toe Syndrome*
;
Cholesterol
;
Humans
;
Iliac Artery
;
Ischemia
;
Leg
;
Middle Aged
;
Rosa
;
Thromboembolism
;
Toes
5.A Case of Antiphospholipid Syndrome Refractory to Secondary Anticoagulating Prophylaxis after Deep Vein Thrombosis-Pulmonary Embolism.
Kang Mo GU ; Jong Wook SHIN ; In Won PARK
Tuberculosis and Respiratory Diseases 2014;77(6):274-278
Antiphospholipid syndrome (APS) is an acquired systemic autoimmune disorder characterized by a combination of clinical criteria, including vascular thrombosis or pregnancy morbidity and elevated antiphospholipid antibody titers. It is one of the causes of deep vein thrombosis and pulmonary embolism that can be critical due to the mortality risk. Overall recurrence of thromboembolism is very low with adequate anticoagulation prophylaxis. The most effective treatment to prevent recurrent thrombosis is long-term anticoagulation. We report on a 17-year-old male with APS, who manifested blue toe syndrome, deep vein thrombosis, pulmonary thromboembolism, and cerebral infarction despite adequate long-term anticoagulation therapy.
Adolescent
;
Antibodies, Antiphospholipid
;
Antiphospholipid Syndrome*
;
Blue Toe Syndrome
;
Cerebral Infarction
;
Cerebrovascular Disorders
;
Embolism*
;
Humans
;
Male
;
Mortality
;
Pregnancy
;
Pulmonary Embolism
;
Recurrence
;
Thromboembolism
;
Thrombosis
;
Veins*
;
Venous Thrombosis
6.Cumulative Patency Rate of Percutaneous Transluminal Angioplasty and Stent Placement for Aortoiliac Occlusive Disease.
Dong Hyun CHOI ; Sang Mok LEE ; Suck Hwan KOH ; Sung Wha HONG ; Soo Myeong OH ; Choong YOON ; Ho Chul PARK ; Ju Hyung OH
Journal of the Korean Society for Vascular Surgery 2004;20(1):70-77
PURPOSE: To evaluate the results of iliac artery angioplasty and stent placement as an option for the treatment of aortoiliac occlusive disease. METHOD: The records of 30 patients (mean age, 65.5 years) who underwent iliac artery angioplasty and/or stent placement were reviewed retrospectively. Presenting symptoms included asymptomatic (6.7%), claudication (73.3%), rest pain (10%), ulceration/tissue loss (3.3%), and blue toe syndrome (6.7%). Follow-up included angioplasty, Doppler ultrasound, and clinical examination. Mean follow-up time was 32 months. RESULT: Forty iliac lesions were treated. Thirty-seven percent of patients had hypertension, 33% had diabetes mellitus, 23% had coronary arterial disease, 6.6% had cerebrovascular disease, 3.3% had hyperlipidemia and 3.3% had renal insufficiency. TASC (Trans Atlantic Inter-Society Consensus) A, B, C and D disease types were 11 (36.7%) patients, 5 (16.7%), 10 (33.3%) and 4 (13.3%). Ipsilateral superficial femoral artery occlusion was present in 6 (20%) patients. Concomitant femoral artery bypass surgery was performed in 10 (33.3%) patients. The cumulative primary patency rates were 83.4%, 71.9% and 64.7% at 1, 2, and 3 years, respectively. CONCLUSION: Iliac artery angioplasty and stent placement is a technically safe and effective treatment modality in patients without ipsilateral superficial femoral artery occlusion.
Angioplasty*
;
Blue Toe Syndrome
;
Diabetes Mellitus
;
Femoral Artery
;
Follow-Up Studies
;
Humans
;
Hyperlipidemias
;
Hypertension
;
Iliac Artery
;
Renal Insufficiency
;
Retrospective Studies
;
Stents*
;
Ultrasonography
7.Blue Toe Syndrome: A Case Report.
Journal of the Korean Society of Plastic and Reconstructive Surgeons 2011;38(4):508-511
PURPOSE: Blue toe syndrome consists of blue or purplish toes in the absence of a history of obvious trauma, serious cold exposure, or disorders producing generalized cyanosis. It is a life-threatening and still underrecognized disease. It can be commonly occurred by vascular surgery, invasive cutaneous procedures or anticoagulant therapy. Our case is presented of blue toe syndrome related to atheromatous embolization that was presumably triggered by angio CT. METHODS: A 69-year-old man presented with the suddenly developed pain, cyanosis and livedo reticularis of the toes in right foot. Dorsalis pedis pulses were palpable. He had been performed a diagnostic angio CT 1 month earlier. Angio CT revealed diffuse aortic atheromatous plaque in lower abdominal aorta and both common iliac artery. One month after angio CT, he visited our clinic. There was no visible distal first dorsal metatarsal artery and digital artery of right first toe in lower extremity arteriography. A diagnosis was established of blue toe syndrome. Because his symptom was aggravated, we performed the exploration of the right foot. After exposure of first dorsal metatarsal artery, microsurgical atheroembolectomy was done. RESULTS: There were no postoperative complications. After three months the patient had no clinically demonstrable problems. CONCLUSION: Patient with blue toe syndrome is at high risk of limb loss and mortality despite treatment. Blue toe syndrome produces painful, cyanosed toes with preserved pedal pulses. It needs to be aware of blue toe syndrome. Careful history should reveal the diagnosis. Treatment is controversial, however, most believe that anticoagulation therapy should be avoided.
Aged
;
Angiography
;
Aorta, Abdominal
;
Arteries
;
Blue Toe Syndrome
;
Cold Temperature
;
Cyanosis
;
Extremities
;
Foot
;
Humans
;
Iliac Artery
;
Livedo Reticularis
;
Lower Extremity
;
Metatarsal Bones
;
Postoperative Complications
;
Toes
8.Blue toe syndrome treated with sympathectomy in a patient with acute renal failure caused by cholesterol embolization.
Min Gang KIM ; Soo Jin KIM ; Jieun OH ; Sung Gyun KIM ; Eun Suck NAM ; Sang Soo KANG
Kidney Research and Clinical Practice 2013;32(4):186-189
Blue toe syndrome is the most frequent manifestation of tissue ischemia caused by cholesterol embolization (CE), which can lead to amputation of affected lower extremities, if severe. However, any effective treatment is lacking. We experienced a case of spontaneously presenting blue toe syndrome and concomitant acute renal failure in a patient with multiple atherosclerotic risk factors. CE was confirmed by renal biopsy. Despite medical treatment including prostaglandin therapy and narcotics, the toe lesion progressed to gangrene with worsening ischemic pain. Therefore, we performed lumbar sympathectomy, which provided dramatic pain relief as well as an adequate blood flow to the ischemic lower extremities, resulting in healing of the gangrenous lesion and avoiding toe amputation. This is the first reported case of a patient with intractable ischemic toe syndrome caused by CE that was treated successfully by sympathectomy. Our observations suggest that sympathectomy may be beneficial in some patients with CE-associated blue toe syndrome.
Acute Kidney Injury*
;
Amputation
;
Biopsy
;
Blue Toe Syndrome*
;
Cholesterol*
;
Embolism, Cholesterol
;
Gangrene
;
Humans
;
Ischemia
;
Lower Extremity
;
Narcotics
;
Risk Factors
;
Sympathectomy*
;
Toes
9.Blue Toe Syndrome after Percutaneous Coronary Intervention.
Hyun Joo LEE ; Won Jeong KIM ; Je Ho MUN ; Hoon Soo KIM ; Hyun Chang KO ; Byung Soo KIM ; Moon Bum KIM ; Margaret SONG
Korean Journal of Dermatology 2015;53(1):66-68
Blue toe syndrome involves blue or purplish toes in the absence of trauma, serious cold exposure, or disorders causing general cyanosis. Clinical presentation can range from a cyanotic toe to a diffuse, multi-organ systemic disease. A 75-year-old man presented with claudication, sudden bilateral painful discoloration of the sole, blue-colored toes, and anuria. Three weeks earlier, he had been diagnosed with acute myocardial infarction and had undergone catheterization for percutaneous coronary intervention. Histopathologic findings showed vascular ectasia with mild perivascular inflammation. Based on patient history, physical examination, and laboratory findings, he was diagnosed with blue toe syndrome. Our patient presented with clinical manifestations, including peripheral cutaneous involvement and acute deterioration of renal function. This case highlights the importance of prompt diagnosis of blue toe syndrome by careful history-taking and physical examination in order to avoid multi-organ systemic disease.
Aged
;
Anuria
;
Blue Toe Syndrome*
;
Catheterization
;
Catheters
;
Cyanosis
;
Diagnosis
;
Dilatation, Pathologic
;
Embolism, Cholesterol
;
Humans
;
Inflammation
;
Myocardial Infarction
;
Percutaneous Coronary Intervention*
;
Physical Examination
;
Toes
10.Blue Digit Syndrome: Treatment with Endarterectomy and Intra-Arterial Stent Placement: 2 Cases Report.
Jeong Nam KWON ; Dong Eun PARK ; Kwon Mook CHAE ; Byung Suk ROH ; Byung Jun SO
Journal of the Korean Society for Vascular Surgery 2003;19(1):94-99
Blue digit syndrome, peripheral atheroembolism, and atheromatous embolization, all refer to microembolization and occlusion of the smaller distal arteries. Despite the longstanding recognition that atheroemboli arise from severely degenerative atherosclerotic plaques in the proximal circulation, many questions remain about the pathophysiology and natural history of this disorder. The threat to the survival of a single digit may not appear to be of great consequence, but repeated episodes of atheroembolism with continued destruction of the collateral circulation may portend disaster for the digit. Diagnostic efforts should be promptly concentrated on the location, stabilization and preferably, eradication of the embolic source. We report 2 cases of blue digit syndrome were managed by endarterectomy and intra-arterial stenting. Case 1: A 61-year-old man was presented with the blue toe syndrome at the third, fourth, fifth toes. The bilateral pedal pulses were normally palpable and ankle-brachial pressure indices (ABI) were within normal range. At the findings of duplex ultrasonography and CT angiography, right common femoral artery showed a focal eccentric stenosis with mural thrombus. The right common femoral artery endarterectomy was performed for the athersclerotic ulcerating plaque. Case 2: A 64-year-old man was presented with 11-month history of his left leg pain and 1-week history of his left third, fourth fingers. He had a history of flap operation for his left fourth finger tip due to necrosis. At the findings of angiography, multiple stenosis of left common iliac and left subclavian arteries were found. The lesion of left subclavian artery lesion was presumed to be the source of blue finger syndrome and treated with intra-arterial stent placement after balloon angioplasty.
Angiography
;
Angioplasty, Balloon
;
Arteries
;
Blue Toe Syndrome
;
Collateral Circulation
;
Constriction, Pathologic
;
Disasters
;
Embolism, Cholesterol
;
Endarterectomy*
;
Femoral Artery
;
Fingers
;
Humans
;
Leg
;
Middle Aged
;
Natural History
;
Necrosis
;
Plaque, Atherosclerotic
;
Reference Values
;
Stents*
;
Subclavian Artery
;
Thrombosis
;
Toes
;
Ulcer
;
Ultrasonography